Inactive Instrument

Gridiron Bionutrients Inc Stock Other OTC

US62847K1025

Chart Gridiron Bionutrients Inc

Duration

Period

Style

Dynamic Chart

Latest news about Gridiron Bionutrients Inc

Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	Jan. 17	CI
Innovation1 Biotech Inc. announced that it has received $0.15 million in funding	Dec. 05	CI
Innovation1 Biotech Inc. announced that it has received $0.02 million in funding	Oct. 31	CI
Innovation1 Biotech Inc. announced that it has received $0.02 million in funding	23-10-10	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	23-09-13	CI
Innovation1 Biotech Inc. announced that it has received $0.066891 million in funding	23-08-31	CI
Innovation1 Biotech Inc. Announces Resignation of Patrick Morris as Chairman of the Board	23-08-11	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	23-05-30	CI
Innovation1 Biotech Inc. Announces Resignation of Jeffrey Kraws as a Director	23-04-24	CI
Innovation1 Biotech Inc. announced that it expects to receive $0.28 million in funding from Cavalry Fund I Management, LLC, Lincoln Park Capital, LLC, L1 Capital Pty. Limited	23-04-12	CI
Innovation1 Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	23-01-17	CI
Innovation1 Biotech Inc. announced that it has received $0.3 million in funding from Cavalry Fund I Management, LLC, L1 Capital Pty. Limited, Lincoln Park Capital, LLC	22-12-26	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	22-12-15	CI
Innovation1 Biotech Inc. Auditor Raises 'Going Concern' Doubt	22-12-14	CI
Innovation1 Biotech Inc. Announces Board Appointments	22-12-12	CI

More news

Press releases Gridiron Bionutrients Inc

Innovation1 Biotech : New Financial Obligation - Form 8-K	23-10-16	PU
Innovation1 Biotech : Material Agreement - Form 8-K	23-04-24	PU
INNOVATION1 BIOTECH INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-04-24	AQ
INNOVATION1 BIOTECH INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	23-01-17	AQ
INNOVATION1 BIOTECH INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	22-12-15	AQ

More press releases

Managers and Directors - Gridiron Bionutrients Inc

Managers	Title	Age	Since
Frederick Pierce CEO	Chief Executive Officer	63	22-09-08
Charles Allen BRD	Director/Board Member	49	22-12-04

Members of the board	Title	Age	Since
Frederick Pierce CEO	Chief Executive Officer	63	22-09-08
Charles Allen BRD	Director/Board Member	49	22-12-04
Shahin Gharakhanian BRD	Director/Board Member	70	22-12-04

More insiders

Innovation1 Biotech Inc. is a shell company. The Company has no operations and is evaluating a number of strategic alternatives including, but not limited to, seeking to acquire a new business in the United States, including potentially by means of a reverse merger with an operating entity. The Company has no sources of revenue.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+107.89%	4.54B
SCREAMING EAGLE ACQUISITION CORP.	+1.89%	1.01B
CHURCHILL CAPITAL CORP VII	+2.00%	980M
ILEARNINGENGINES, INC.	-35.43%	963M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+25.02%	809M
ARES ACQUISITION CORPORATION II	+1.63%	664M
E7 GROUP	+0.90%	612M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M

Shell Companies

Sales 2022	-	Sales 2023	-	Capitalization	17.4M
Net income 2022	-40M	Net income 2023	-5M	EV / Sales 2022	-
Net Debt 2022	351K	Net Debt 2023	179K	EV / Sales 2023	-
P/E ratio 2022	-0.06 x	P/E ratio 2023	-1.22 x	Employees	-
Yield 2022 *	-	Yield 2023	-	Free-Float	33.95%